Navigation Links
Lucid, Inc. Reflects New Vision with Name Change to Caliber Imaging & Diagnostics, Inc.
Date:8/16/2012

ROCHESTER, N.Y., Aug. 16, 2012 /PRNewswire/ -- Lucid, Inc. announced today that, effective immediately, it is operating under a new company name, Caliber Imaging & Diagnostics, Inc., or Caliber ID. The new name reflects the company's commitment to innovating and delivering the highest caliber identification tools for accurate, rapid diagnosis to assist in the fight against skin cancer and other diseases.

(Logo:  http://photos.prnewswire.com/prnh/20120816/NY57816LOGO )

Caliber ID has created an entirely new class of tools enabling physicians to image and diagnose skin disease in real time without a biopsy. These devices using Caliber ID's reflectance confocal microscopy (RCM) technology allow physicians to detect and diagnose skin disease, including basal cell carcinoma, melanoma, and inflammatory and pigmentary disorders. Caliber ID's RCM technology offers physicians the option to non-invasively diagnose, monitor and follow-up the non-invasive treatment of basal cell carcinoma, the most commonly diagnosed cancer in mankind, and includes the capacity to visualize the margins of the disease prior to surgery, improving patient outcomes.  

"This technology is clearly a clinically-relevant diagnostic tool," notes Dr. Martin C. Mihm Jr., Associate Physician at Brigham and Women's Hospital, Clinical Professor of Pathology (Dermatology) at Harvard Medical School and chair of the Caliber ID scientific advisory board. "The clinical data indicates that this suite of technologies can substantially reduce the need to biopsy healthy tissue by giving physicians the ability to noninvasively image and diagnose skin cancers and other skin disease. In the hands of an experienced confocal user, resolution and accuracy is comparable to that of traditional histology."

The Company has developed an integrated platform of tools, including the Caliber ID VivaScope® 1500 and VivaScope® 3000 imagers along with Caliber ID's telepathology service that can be used by doctors, surgeons, and research laboratories. Its tools are already in use by doctors and researchers in major academic hospitals including Memorial Sloan Kettering (New York, NY), Brigham and Women's Hospital (Boston, MA), the Charite Hospital in Berlin (GERMANY) and the Melanoma Institute Australia (Sydney, AUSTRALIA).

About Caliber ID

Caliber ID's platform of products offer increased productivity from the doctor's office to the surgeon's operating room. Today, the future of skin cancer diagnosis is here: an integrated platform of tools and technology for accurate diagnoses quickly and routinely. Caliber ID products provide precise accuracy, consistent reliability, and online backup that all combine to lead to life-saving early diagnosis. Wherever you are in the continuum of skin imaging and diagnosis, this is not just best in class. This is a new class. For more information about Caliber ID and its products, please visit www.caliberid.com

VivaScope® is a registered trademarks of Caliber ID.

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed with the SEC.

Contact:
Caliber Imaging & Diagnostics, Inc.
Rich Pulsifer
Phone: (585) 758-2813
Fax: (585) 239-9806  


'/>"/>
SOURCE Caliber Imaging & Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NAMS Journal Menopause Reflects on the WHI 10 Years Later
2. Academy of Managed Care Pharmacy (AMCP) Helps Explain Health Care Laws Contraception Coverage Provision
3. Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
4. ANSYS Signs Master Agreement with EADS to provide simulation tools to all its divisions
5. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
6. Pediatrician Finds New Vision Screening Technology Helps A Larger Group Of His Patients
7. BioSurplus Forms New Division for Auction Services
8. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
9. Transitions Optical Brings Importance Of Healthy, Enhanced Vision Into Focus By Taking National Sightseeing City Tour To Chicago And Announcing The Citys Top 10 Sights To See
10. Spot Vision Screener wins Bronze in International Design Excellence Awards
11. DataMotion Files Provisional Patent for Technology that Enables Easy and Secure Doctor-Patient Email Interaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... YORK , April 19, 2017 The Mobile ... to showcase a healthy CAGR during the forecast period ... type in the global digital mobile X-Ray devices market, which ... Mn in 2017, expanding at a CAGR of 7% over ... absolute $ opportunity of more than US$ 100 Mn in ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... ... Association’s Outstanding Public Communication of Education Research Award. The award honors scholars exemplary ... communities. It recognizes a scholar who has demonstrated the capacity to deepen the ...
(Date:4/24/2017)... ... 2017 , ... Veteran Theresa James awoke to the sound of her newly ... “Healing Tears,” James depicts every parent’s worst nightmare, when her three children were violently ... and situations throughout my divorce,” James said. “After the death of my children, I ...
(Date:4/24/2017)... Waycross, Ga. (PRWEB) , ... April 24, 2017 ... ... and trusted advisor within the telehealth industry, announces the company’s VideoMedicine mobile platform ... primary care providers. Available 24 hours a day, Quick Care provides patients with ...
(Date:4/24/2017)... ... 2017 , ... Rod Burkett, CEO of Gardant Management Solutions, was recently featured ... at the forefront of Gardant since it was founded in 1999. His drive and ... of more than 40 new senior living communities. With his leadership, Gardant has grown ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all ... found any of them to be very practical. She wanted to write a guide/workbook ... changes in their health. It prompted her in writing “ A Clear Path to ...
Breaking Medicine News(10 mins):